Johnson & Johnson Single-Shot COVID-19 Vaccine Phase 3 Data Published in New England Journal of Medicine

NEW BRUNSWICK, N.J., April 21, 2021 – Johnson &Johnson (the Company) today announced publication in the New England Journal of Medicine of primary data from the Phase 3 ENSEMBLE clinical trial for its single-dose COVID-19 vaccine, developed by the Janssen Pharmaceutical Companies of Johnson &Johnson (Janssen). The publication of the primary analysis follows the topline efficacy and safety data announced in January, showing the trial met all primary and key secondary endpoints, and found that the Johnson &Johnson single-dose COVID-19 vaccine prevented hospitalization and death across all study participants 28 days after vaccination. These data demonstrated that, despite the high prevalence of emerging SARS-CoV-2 variants among COVID-19 cases in the study, including the South African variant of the B.1.351 lineage and the P2 lineage variant found in Brazil, vaccine efficacy was consistent against symptomatic infection, and the vaccine showed protection against COVID-19-related hospitalization and death as of 28 days after vaccination.“This comprehensive evidence demonstrates that Johnson &Johnson’s single-shot COVID-19 vaccine offers protection and prevents hospitalization and death, including in countries where viral variants are highly prevalent,” said Paul Stoffels, M.D., Vice Chairman of the Executive Committee and Chief Scientific Officer at Johnson &Johnson. “Regardless of race and ethnicity, age, geographic location and c...
Source: Johnson and Johnson - Category: Pharmaceuticals Tags: Our Company Source Type: news

Related Links:

The vaccines may well continue to ward off severe illness and death, although booster doses may be needed to protect most people. Still, the makers of the two most effective vaccines, Pfizer-BioNTech and Moderna, are preparing to reformulate their shots if necessary.
Source: bizjournals.com Health Care:Physician Practices headlines - Category: American Health Authors: Source Type: news
Both cases are recent arrivals from Nigeria;UN agency ’s comments follow South Africa’s call to reverse flight bans;G7 health ministers to hold urgent meeting on Omicron variantAt least 13 of 61 cases on two flights into Netherlands are new variantOmicron ’s worst impact will be in nations with low vaccination ratesWhat do we know about the new ‘worst ever’ Covid variant?See all our coronavirus coverageChina could face more than 630,000 Covid-19 infections a dayif it dropped its zero-tolerance policies by lifting travel curbs, according to a study by Peking University mathematicians, Reuters r...
Source: Guardian Unlimited Science - Category: Science Authors: Tags: World news Coronavirus Science UK news Europe US news Source Type: news
The most popular medication to treat high blood pressure is not as effective as this drug.
Source: PsyBlog | Psychology Blog - Category: Psychiatry & Psychology Authors: Tags: Blood Pressure Source Type: blogs
Healthcare IT company Novarad is set to offer lung cancer screening softwar...Read more on AuntMinnie.comRelated Reading: Novarad launches new version of CryptoChart Novarad signs deal with health center in Iowa Novarad debuts free AI software for COVID-19 PenRad debuts patient notification software PenRad gives lung CT tracker to imaging centers
Source: AuntMinnie.com Headlines - Category: Radiology Source Type: news
Last week I described some of the reasons for using a case formulation approach when working through initial assessment information, and today I’m going to describe one approach for organising a formulation. This is the “4 P” formulation, and it’s one that’s often used in mental health (Bolton, 2014). In the 4 P model, there are four questions to ask yourself: Preconditions – Why is this person vulnerable to this problem?Precipitating factors – Why now? This can mean “why is this person having symptoms now?” or “why is this person presenting to this person ...
Source: HealthSkills Weblog - Category: Anesthesiology Authors: Tags: Assessment Chronic pain Clinical reasoning Pain conditions Professional topics Research Science in practice biopsychosocial case formulation Occupational therapy pain management Therapeutic approaches Source Type: blogs
We find out how much protection Covid vaccines may offer amid speculation new variant could be more resistantCoronavirus – latest updatesSee all our coronavirus coverageThe emergence of Omicron has prompted widespread speculation that it may be more resistant to Covid-19 vaccines than existing variants, including Delta. But what does that mean for the average double-vaccinated person?All the vaccines currently available in the UK work by training the immune system against the coronavirus spike protein – the key it uses to infect cells by binding to the ACE2 receptor. Omicron possesses more than 30 mutations in ...
Source: Guardian Unlimited Science - Category: Science Authors: Tags: Coronavirus Vaccines and immunisation UK news Health Society Science Immunology Source Type: news
Digital breast tomosynthesis (DBT) has shown itself to be a valid, beneficia...Read more on AuntMinnie.comRelated Reading: DBT can help evaluate cases of focal breast pain DBT + synthesized 2D mammo detects more cancers Mammography, DBT safe for accidental exam during pregnancy DBT screening shows value in community practice settings Synthesized mammo plus DBT handles calcifications differently
Source: AuntMinnie.com Headlines - Category: Radiology Source Type: news
Source: BMJ Comments - Category: General Medicine Source Type: forums
Mallory Weggemann​ Mallory Weggemann on the Terrifying Moment She Was Paralyzed by an Epidural Shot: 'I Felt This Spark of Pain' Mallory Weggemann, now 31, was just a teen when she was paralyzed after a medical procedure people.com
Source: Student Doctor Network - Category: Universities & Medical Training Authors: Tags: Pain Medicine Source Type: forums
Healthcare IT company Novarad is set to be the exclusive distributor of CureMetri...Read more on AuntMinnie.comRelated Reading: Novarad launches new version of CryptoChart Novarad signs deal with health center in Iowa CureMetrix appoints new executive vice president CureMetrix highlights mammo AI study results Ikonopedia partners with CureMetrix Novarad debuts free AI software for COVID-19
Source: AuntMinnie.com Headlines - Category: Radiology Source Type: news
More News: Allergy | Allergy & Immunology | Argentina Health | Biotechnology | Bleeding | Brain | Brazil Health | Breastfed | Cancer & Oncology | Cardiology | Cardiovascular | Centers for Disease Control and Prevention (CDC) | Chemistry | Chile Health | Clinical Trials | Colombia Health | Contracts | Coronavirus | COVID-19 | Department of Health | Diabetes | Diabetes Type 2 | Eating Disorders & Weight Management | Ebola | Ebola Vaccine | Emergency Medicine | Endocrinology | Environmental Health | Flu Pandemic | Food and Drug Administration (FDA) | Headache | Health Management | Heart | Hospitals | Hypertension | Iceland Health | India Health | Infectious Diseases | Influenza | Influenza Vaccine | International Medicine & Public Health | Learning | Legislation | Marketing | Men | Mexico Health | Migraine | National Institutes of Health (NIH) | Neurology | Neuroscience | Norway Health | Obesity | Pain | Pain Management | Pandemics | Peru Health | Pharmaceuticals | Pregnancy | Profits and Losses | Pulmonary Hypertension | Respiratory Medicine | SARS | Science | Skin | South Africa Health | Study | Universities & Medical Training | USA Health | Vaccines | WHO | Zika Virus